Company Filing History:
Years Active: 2010
Title: Innovations of Mark Kopnitsky: Advancements in Assay Methods
Introduction: Mark Kopnitsky, an inventor based in Easton, PA, has made significant contributions to the field of biochemical assays. With a keen focus on improving detection methods, Kopnitsky was awarded a patent that enhances the reliability and accuracy of detecting and measuring analytes, such as antibodies.
Latest Patents: Kopnitsky holds one patent entitled "Method and Composition for Homogeneous Multiplexed Microparticle-Based Assay." This innovative method allows for the detection of specific antibodies through a homogeneous assay performed in the presence of free unbound antibodies. By utilizing test subsets of microparticles with specific antigens, this method can bind with target antibodies effectively. Additionally, the suspension includes calibration subsets with known concentrations, ensuring precise assay calibration.
Career Highlights: Currently, Mark Kopnitsky is affiliated with Zeus Scientific, Inc., where he applies his knowledge and expertise to advance the company's mission in development and innovation in assay technologies. His work helps in providing vital tools for diagnostic purposes, pushing the boundaries of scientific understanding in the field.
Collaborations: Throughout his career, Kopnitsky has collaborated with notable colleagues, including Mark Carle Connelly. Together, they explore groundbreaking methods and contribute to the collective goal of enhancing assay performance and accuracy.
Conclusion: Mark Kopnitsky's dedication to innovation within the realm of biochemical assays exemplifies the role of inventors in scientific progress. His patented method demonstrates the potential for improved diagnostics, making a significant impact on the industry and paving the way for future advancements in assay technologies.